Dolutegravir 25 mg and 50 mg and Tacrolimus Extended-Release Tablets
Determining the interaction of Dolutegravir 25 mg and 50 mg and Tacrolimus Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dolutegravir
Brand name: Tivicay
Synonyms: Dolutegravir
Generic Name: tacrolimus
Brand name: Astagraf XL, Envarsus XR, Prograf, Hecoria
Synonyms: Tacrolimus (oral and injection), Tacrolimus (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dolutegravir 25 mg and 50 mg-Tacrolimus Granules for Suspension
- Dolutegravir 25 mg and 50 mg-Tacrolimus Injection
- Dolutegravir 25 mg and 50 mg-Tacrolimus Intravenous
- Dolutegravir 25 mg and 50 mg-Tacrolimus oral and injection
- Dolutegravir 25 mg and 50 mg-Tacrolimus Oral, Intravenous
- Dolutegravir 25 mg and 50 mg-Tactinal
- Tacrolimus Extended-Release Tablets-Dolutegravir and lamivudine
- Tacrolimus Extended-Release Tablets-Dolutegravir and rilpivirine
- Tacrolimus Extended-Release Tablets-Dolutegravir Sodium
- Tacrolimus Extended-Release Tablets-Dolutegravir Sodium And Lamivudine
- Tacrolimus Extended-Release Tablets-Dolutegravir Sodium and Rilpivirine Hydrochloride
- Tacrolimus Extended-Release Tablets-Dom-Etoposide